Advancements in the Treatment of Hepatocellular Carcinoma
This webinar will focus on assessing patient populations at highest risk, current and emerging treatment options for HCC, and strategies to increase adherence and minimize adverse effects in order to enhance patient outcomes.
HOPA Satellite Symposium: Oncology Pharmacy Perspectives: Evolving Strategies for BTK Inhibitors in B-Cell Malignancies
This CE symposium will distinguish the epidemiology, etiology, and pathophysiology of various B-cell malignancies, including their link to BTK in the B-cell receptor (BCR) pathway
Pharmacists Reaching Out®: Optimizing Patient Management in HR+, HER2- Advanced Breast Cancer, the Role of CDK4/6 Inhibition
This program will address specific patient education and counseling points for pharmacists to discuss with patients receiving these agents.
The Expanding Treatment Landscape of Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
This broadcast will examine the genetic mutations and biomarkers commonly encountered in follicular lymphoma and mantle cell lymphoma